EMA’s human medicines committee elects new Chair
Submitted by Anonymous (not verified) on 18 September 2024 - 14:18
EMA’s human medicines committee elects new Chair
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 09:30 (CEST) to 1 July 2024, 11:45 (CEST)
Submitted by Anonymous (not verified) on 18 September 2024 - 13:36
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 09:30 (CEST) to 1 July 2024, 11:45 (CEST)
Minutes – Ad-hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2024
Submitted by Anonymous (not verified) on 18 September 2024 - 13:33
Minutes – Ad-hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2024
Withdrawn application: Ontilyv, 12/03/2024
Submitted by Anonymous (not verified) on 18 September 2024 - 12:00
Withdrawn application: Ontilyv, 12/03/2024
Withdrawn application: Ongentys, 12/03/2024
Submitted by Anonymous (not verified) on 18 September 2024 - 11:45
Withdrawn application: Ongentys, 12/03/2024
Herbal medicinal product: Absinthii herbaArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 18 September 2024 - 10:20
Herbal medicinal product: Absinthii herbaArray, F: Assessment finalised
Human medicines European public assessment report (EPAR): Pomalidomide Accord, pomalidomide, Date of authorisation: 26/07/2024, Status: Authorised
Submitted by Anonymous (not verified) on 17 September 2024 - 15:40
Human medicines European public assessment report (EPAR): Pomalidomide Accord, pomalidomide, Date of authorisation: 26/07/2024, Status: Authorised
Human medicines European public assessment report (EPAR): Vemlidy, tenofovir alafenamide, Date of authorisation: 09/01/2017, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 17 September 2024 - 14:43
Human medicines European public assessment report (EPAR): Vemlidy, tenofovir alafenamide, Date of authorisation: 09/01/2017, Revision: 17, Status: Authorised
Agenda - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (18 September 2024)
Submitted by Anonymous (not verified) on 17 September 2024 - 13:03
Agenda - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (18 September 2024)
Pharmacovigilance Risk Assessment Committee (PRAC) criteria to prioritise impact research (Rev.1)
Submitted by Anonymous (not verified) on 17 September 2024 - 12:54
Pharmacovigilance Risk Assessment Committee (PRAC) criteria to prioritise impact research (Rev.1)